Myasthenia gravis in childhood

被引:24
作者
Anlar, B
Ozdirim, E
Renda, Y
Yalaz, K
Aysun, S
Topcu, M
Topaloglu, H
机构
[1] Hacettepe University, Department of Paediatric Neurology, Ankara
[2] Hacettepe University, Department of Paediatric Neurology
关键词
acetylcholine receptor; acetylcholine receptor antibodies; autoimmunity; myasthenia gravis;
D O I
10.1111/j.1651-2227.1996.tb14162.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Clinical features, serum acetylcholine receptor antibody (AChRAb) titres and course were reviewed in a series of 25 congenital (CMG) and 30 juvenile (JMG) myasthenia gravis cases to recognize characteristics of childhood-onset myasthenia and its subgroups. The initial symptom for CMG is ptosis accompanied or followed by generalized weakness; myasthenic crises do not occur and spontaneous remissions are rare. In JMG, the distribution of weakness remains the same, but the severity fluctuates: spontaneous remissions (6 patients) and myasthenic crises (10 patients) are observed. Good response to anticholinesterase drugs is slightly more frequent in JMG (62 versus 41%). AChRAbs were present in 9/26 JMG tested, girls with onset after 11 years being more likely to be Ab-positive. Since patients with autoimmune myasthenia and a young age of onset are often seronegative, clinical features such as changing distribution of weakness, fluctuating severity, or response to treatment might be considered as supportive criteria for differentiating JMG from CMC.
引用
收藏
页码:838 / 842
页数:5
相关论文
共 21 条
[1]   TESTS FOR JUVENILE MYASTHENIA-GRAVIS - COMPARATIVE DIAGNOSTIC YIELD AND PREDICTION OF OUTCOME [J].
AFIFI, AK ;
BELL, WE .
JOURNAL OF CHILD NEUROLOGY, 1993, 8 (04) :403-411
[2]   RACE, SEX, AND PUBERTY INFLUENCE ONSET, SEVERITY, AND OUTCOME IN JUVENILE MYASTHENIA-GRAVIS [J].
ANDREWS, PI ;
MASSEY, JM ;
HOWARD, JF ;
SANDERS, DB .
NEUROLOGY, 1994, 44 (07) :1208-1214
[3]   ACETYLCHOLINE-RECEPTOR ANTIBODIES IN JUVENILE MYASTHENIA-GRAVIS [J].
ANDREWS, PI ;
MASSEY, JM ;
SANDERS, DB .
NEUROLOGY, 1993, 43 (05) :977-982
[4]   FAMILIAL AUTOIMMUNE MYASTHENIA-GRAVIS [J].
BERGOFFEN, J ;
ZMIJEWSKI, CM ;
FISCHBECK, KH .
NEUROLOGY, 1994, 44 (03) :551-554
[6]   A NEWLY RECOGNIZED CONGENITAL MYASTHENIC SYNDROME ATTRIBUTED TO A PROLONGED OPEN TIME OF THE ACETYLCHOLINE-INDUCED ION CHANNEL [J].
ENGEL, AG ;
LAMBERT, EH ;
MULDER, DM ;
TORRES, CF ;
SAHASHI, K ;
BERTORINI, TE ;
WHITAKER, JN .
ANNALS OF NEUROLOGY, 1982, 11 (06) :553-569
[7]  
ENGEL AG, 1990, PROG BRAIN RES, V84, P125
[8]   A CLINICAL APPROACH TO THE CONGENITAL MYASTHENIC SYNDROMES [J].
JANAS, JS ;
BAROHN, RJ .
JOURNAL OF CHILD NEUROLOGY, 1995, 10 (02) :168-169
[9]   EXACERBATION OF MYASTHENIA-GRAVIS AFTER REMOVAL OF A THYMOMA HAVING A MEMBRANE PHENOTYPE OF SUPPRESSOR T-CELLS [J].
KURODA, Y ;
ODA, K ;
NESHIGE, R ;
SHIBASAKI, H .
ANNALS OF NEUROLOGY, 1984, 15 (04) :400-402
[10]   ANTIBODY TO ACETYLCHOLINE-RECEPTOR IN MYASTHENIA-GRAVIS - PREVALENCE, CLINICAL CORRELATES, AND DIAGNOSTIC VALUE [J].
LINDSTROM, JM ;
SEYBOLD, ME ;
LENNON, VA ;
WHITTINGHAM, S ;
DUANE, DD .
NEUROLOGY, 1976, 26 (11) :1054-1059